Fallopian tube cancer Trials in New York, United States
Conditions / Fallopian tube cancer / New York, United States
Research into Fallopian tube cancer spans multiple therapeutic approaches and trial phases.
88 total trials for this combination
Showing top 10 of 88 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05445778 | Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer | RECRUITING | PHASE3 |
| NCT05377996 | A Study of XMT-1660 in Participants With Solid Tumors | RECRUITING | — |
| NCT02657889 | Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT05788484 | A Study of CDX-585 in Patients With Advanced Malignancies | COMPLETED | PHASE1 |
| NCT05377996 | A Study of XMT-1660 in Participants With Solid Tumors | RECRUITING | — |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | COMPLETED | PHASE1 |
| NCT03872947 | A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT05377996 | A Study of XMT-1660 in Participants With Solid Tumors | RECRUITING | — |
| NCT01493505 | TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | TERMINATED | PHASE3 |
| NCT03038100 | A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | COMPLETED | PHASE3 |